Literature DB >> 6416398

Hyposensitisation to wasp venom in six hours.

J C van der Zwan, J Flinterman, I G Jankowski, J A Kerckhaert.   

Abstract

Eleven patients with a history of anaphylaxis, positive reactions to skin tests, and specific IgE antibody to wasp venom underwent hyposensitisation in a six hour procedure. No general reactions occurred. Complement activation and proteinuria could not be shown. The patterns of specific IgE, IgG1, and IgG4 were as described in other procedures--namely, IgE increased sharply and then decreased; IgG1 and IgG4 increased steadily and then decreased--but increase and decrease came earlier. Challenge by a stinging insect at least four weeks after treatment proved complete protection. The skin reactivity two years later showed an unpredictable pattern.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416398      PMCID: PMC1549515          DOI: 10.1136/bmj.287.6402.1329

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

Review 1.  Role of antigen structure in the discrimination between tolerance and immunity by b cells.

Authors:  M Feldmann; J G Howard; C Desaymard
Journal:  Transplant Rev       Date:  1975

2.  Deaths from bites and stings of venomous animals and insects in the United States.

Authors:  H M PARRISH
Journal:  AMA Arch Intern Med       Date:  1959-08

3.  Insect allergy: the state of the art.

Authors:  L M Lichtenstein; M D Valentine; A K Sobotka
Journal:  J Allergy Clin Immunol       Date:  1979-07       Impact factor: 10.793

4.  A case for venom treatment in anaphylactic sensitivity to hymenoptera sting.

Authors:  L M Lichtenstein; M D Valentine; A K Sobotka
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

5.  Frequency of Hymenoptera allergy in an atopic and normal population.

Authors:  G A Settipane; G J Newstead; G K Boyd
Journal:  J Allergy Clin Immunol       Date:  1972-09       Impact factor: 10.793

6.  A controlled trial of immunotherapy in insect hypersensitivity.

Authors:  K J Hunt; M D Valentine; A K Sobotka; A W Benton; F J Amodio; L M Lichtenstein
Journal:  N Engl J Med       Date:  1978-07-27       Impact factor: 91.245

7.  Rush venom immunotherapy program for honeybee sting sensitivity.

Authors:  J W Yunginger; B R Paull; R T Jones; P J Santrach
Journal:  J Allergy Clin Immunol       Date:  1979-05       Impact factor: 10.793

8.  Regimens of Hymenoptera venom immunotherapy.

Authors:  D B Golden; M D Valentine; A Kagey-Sobotka; L M Lichtenstein
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

9.  Measurement of IgG-blocking antibodies: development and application of a radioimmunoassay.

Authors:  A K Sobotka; M D Valentine; K Ishizaka; L M Lichtenstein
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

10.  Specific selection of antigen-reactive lymphocytes into antigenically stimulated lymph nodes in sheep.

Authors:  J Hopkins; I McConnell; P J Lachmann
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Safety considerations in assessing the role of immunotherapy in allergic disorders.

Authors:  J Bousquet; F B Michel
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

2.  Induction of specific immunotherapy with hymenoptera venoms using ultrarush regimen in children: safety and tolerance.

Authors:  Alice Köhli-Wiesner; Lisbeth Stahlberger; Christian Bieli; Tamar Stricker; Roger Lauener
Journal:  J Allergy (Cairo)       Date:  2011-07-19

3.  Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol.

Authors:  Vincenzo Patella; Giovanni Florio; Ada Giuliano; Carmine Oricchio; Giuseppe Spadaro; Gianni Marone; Arturo Genovese
Journal:  J Allergy (Cairo)       Date:  2012-05-24

Review 4.  Clinical Utility of Rush Venom Immunotherapy: Current Status.

Authors:  Vianney Gruzelle; Claire Mailhol; David W Waters; Laurent Guilleminault
Journal:  J Asthma Allergy       Date:  2020-01-07

5.  Twelve-hour ultrarush immunotherapy in a patient with mastocytosis and hymenoptera sting anaphylaxis.

Authors:  Doris Jäger; Jürgen Barth
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.